Ionic liquid–engineered ibrexafungerp citrate cubosomal gel for Candidiasis: Formulation, and in vitro–in vivo characterization
Microbial Pathogenesis · 2027-01 · 222 · 108900
DOI: 10.1016/j.micpath.2026.108900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2027-01. Verfasst von Suraj M Ambale und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Scholar, NIMS Institute of Pharmacy, NIMS University, Jaipur, 303121, Rajasthan, India. Die Arbeit nennt 99 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Scholar, NIMS Institute of Pharmacy, NIMS University, Jaipur, 303121, Rajasthan, India.
- NIMS Institute of Pharmacy, NIMS University, Jaipur, Rajasthan, 303121, India. Electronic address: meenayadav82@gmail.com.
- Department of Pharmaceutics, Vasantidevi Patil Institute of Pharmacy, Kodoli, 416114, Kolhapur, Maharashtra, India. Electronic address: gsunil201288@gmail.com.
Zitieren
APA
Ambale, S. M., Yadav, M. K., & Galatage, S. T. (2027). Ionic liquid–engineered ibrexafungerp citrate cubosomal gel for Candidiasis: Formulation, and in vitro–in vivo characterization. Microbial Pathogenesis, 222, 108900. https://doi.org/10.1016/j.micpath.2026.108900
Vancouver
Ambale SM, Yadav MK, Galatage ST. Ionic liquid–engineered ibrexafungerp citrate cubosomal gel for Candidiasis: Formulation, and in vitro–in vivo characterization. Microbial Pathogenesis. 2027;222:108900. doi:10.1016/j.micpath.2026.108900
BibTeX
@article{Ambale2027,
author = {Ambale, Suraj M and Yadav, Meena K and Galatage, Sunil T},
title = {Ionic liquid–engineered ibrexafungerp citrate cubosomal gel for Candidiasis: Formulation, and in vitro–in vivo characterization},
journal = {Microbial Pathogenesis},
year = {2027},
volume = {222},
pages = {108900},
doi = {10.1016/j.micpath.2026.108900}
}
EUVIMED